WHO online guide on the use of digital technologies for tuberculosis programmes

Onno W Akkerman^{1

2

3}, Dennis Falzon^{4

3}, Giovanni Battista Migliori^{5

3}, Olha Konstantynovska⁶, Fusun Oner Eyuboglu⁷, Charalambos Sismanidis⁴, Avinash Kanchar⁴, Raquel Duarte^{8

9

10

11}

Affiliations

¹ University of Groningen, University Medical Center Groningen, Department of Pulmonary diseases and Tuberculosis, Groningen, The Netherlands o.w.akkerman@umcg.nl.
² University of Groningen, University Medical Center Groningen, TB Center Beatrixoord, Groningen, The Netherlands.
³ O.W. Akkerman, D. Falzon and G.B. Migliori contributed equally.
⁴ World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.
⁵ Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Varese, Italy.
⁶ V.N. Karazin Kharkiv National University, Department of Infectious Diseases and Clinical Immunology, Kharkiv, Ukraine.
⁷ FOE Respiratory Clinic, Baskent University Division of Pulmonary Diseases, Ankara, Turkey.
⁸ EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
⁹ Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
¹⁰ ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
¹¹ Centro de Saúde Pública Doutor Gonçalves Ferreira - Instituto de Saúde Pública Doutor Ricardo Jorge (INSA-Porto), Porto, Portugal.

Editorial

Onno W Akkerman et al. Eur Respir J. 2025.

. 2025 Jun 19;65(6):2401126.

doi: 10.1183/13993003.01126-2024. Print 2025 Jun.

¹ University of Groningen, University Medical Center Groningen, Department of Pulmonary diseases and Tuberculosis, Groningen, The Netherlands o.w.akkerman@umcg.nl.
² University of Groningen, University Medical Center Groningen, TB Center Beatrixoord, Groningen, The Netherlands.
³ O.W. Akkerman, D. Falzon and G.B. Migliori contributed equally.
⁴ World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.
⁵ Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Varese, Italy.
⁶ V.N. Karazin Kharkiv National University, Department of Infectious Diseases and Clinical Immunology, Kharkiv, Ukraine.
⁷ FOE Respiratory Clinic, Baskent University Division of Pulmonary Diseases, Ankara, Turkey.
⁸ EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
⁹ Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
¹⁰ ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
¹¹ Centro de Saúde Pública Doutor Gonçalves Ferreira - Instituto de Saúde Pública Doutor Ricardo Jorge (INSA-Porto), Porto, Portugal.

No abstract available

Conflict of interest statement

Conflict of interest: The authors have no potential conflicts of interest to disclose.